Walleye Trading’s ANI Pharmaceuticals ANIP Stock Holding History

Walleye Trading’s Portfolio ANIP Stock Details ANIP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-25,600	Closed	-$743K	–	4759
2020 Q4	$743K	Sell	25,600 -43,900	-63%	-$1.26M	﹤0.01%	2298
2020 Q3	$1.96M	Buy	69,500 +8,200	+13%	+$244K	0.01%	1134
2020 Q2	$1.98M	Buy	61,300 +13,000	+27%	+$466K	0.01%	1102
2020 Q1	$1.97M	Buy	48,300 +30,500	+171%	+$1.62M	0.02%	838
2019 Q4	$1.1M	Buy	17,800 +10,300	+137%	+$682K	0.01%	1718
2019 Q3	$547K	Sell	7,500 -1,700	-18%	-$127K	﹤0.01%	2067
2019 Q2	$756K	Sell	9,200 -14,100	-61%	-$1M	0.01%	1832
2019 Q1	$1.64M	Buy	23,300 +16,600	+248%	+$977K	0.01%	1240
2018 Q4	$302K	Buy	+6,700	New	+$351K	﹤0.01%	2972

Other funds holding ANIP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

ICOM

Investment Counselors of Maryland Baltimore, Maryland $4.37B AUM 76.25% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

TSW

Thompson Siegel & Walmsley Richmond, Virginia $5.57B AUM 9.46% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

FWSM

First Wilshire Securities Management Pasadena, California $486M AUM 50.29% 1-Year Est. Return

Walleye Trading's ANIP Position: Q1 2021 in Review

Walleye Trading sold out of ANI Pharmaceuticals (ANIP) in Q1 2021, closing a stake of 3,389 shares — an estimated $98K sold.

Walleye Trading first reported a position in ANIP in Q3 2016 and held it in 5 quarters. The position peaked at $246K in Q2 2019. 106 funds tracked by Wall St. Rank hold ANIP as of Q1 2021.

Walleye Trading reported no remaining ANI Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
Walleye Trading sold 3,389 ANI Pharmaceuticals shares in Q1 2021, an estimated $98K.
Walleye Trading first reported a position in ANI Pharmaceuticals in Q3 2016 and held it in 5 quarters.
Walleye Trading's ANI Pharmaceuticals position peaked at $246K in Q2 2019.
106 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q1 2021.

Based on Walleye Trading's 13F filing for Q1 2021, filed 17 May 2021.